McKesson Corporation Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance
McKesson Corporation (NYSE: MCK) has released its fiscal 2025 second quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S.
In a report released today, Stephanie Davis from Barclays maintained a Buy rating on McKesson (MCK – Research Report), with a price target of $668.00. The company’s shares closed yesterday at ...
We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...
Chicago Partners Investment Group LLC increased its stake in shares of McKesson Co. (NYSE:MCK – Free Report) by 17.0% during ...
Zacks.com on MSN12h
McKesson (MCK) Q2 Earnings and Revenues Beat EstimatesMcKesson (MCK) delivered earnings and revenue surprises of 2.61% and 4.66%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Sen. Elizabeth Warren calls on FTC to block medical distributors McKesson (MCK) and Cardinal Health's (MCK) recent deals to ...
Arkadios Wealth Advisors boosted its stake in McKesson Co. (NYSE:MCK – Free Report) by 43.7% in the 3rd quarter, according to ...
In what is shaping up to be an increasingly active term for judicial scrutiny of agency deference, the U.S. Supreme Court granted certiorari ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback